Every year, the MEDEF, France’s largest entrepreneurial organisation, sets up local conferences in an attempt to bring companies together under a predefined theme. This year, Genoskin was invited to the 7th Edition of the Entrepreneurial Event (Grande Tribune des Entrepreneurs) to contribute to the discussion on the role of CEOs in driving change. The widely attended conference was headed by Pierre Gataz, the MEDEF’s president (see
Genoskin attended the 9th World Congress On Alternatives and Animal Use in The Life Sciences (WC9 2014) organized in Prague, Czech Republic, from the 24 to the 28 August. “The world congress provides an exceptional forum to underline the importance of both the ethical issues of animal experimentation and the approach to the life sciences in the 21st century.”
Genoskin has presented its ex vivo human skin explant model, NativeSkin®, during labcourses focused on skin drug delivery and organized at the Bio Barrier 2014 congress in Saarbrücken, Germany.
Genoskin will present its technology NativeSkin® at the Cosminnov 2013 congress organized in Orléans, France on October 8th and 9th. Importantly, two of our partners,
We are very pleased to announce that our technology NativeSkin will be presented in a nice study done by LEO Pharma and us at the International Investigative Dermatology annual meeting.